RTA certificate under Reg 74(5) for Q2 FY27 filed

Compliance View source PDF Explain this filing

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹1905.00

prior close

₹1899.90

announcement price

In-mkt

timing

Nifty Midcap 150market+0.1%-0.7% vs market

Pharmaceuticals peers, median of 167sector-0.1%-0.5% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7+0.1-0.7-0.1-0.5

Next day

+0.1+1.0-0.9-0.1+0.2

+0.3+1.0-0.7-0.3+0.6

+0.2+0.7-0.6-1.0+1.1

-3.1+0.6-3.8-0.7-2.4

-5.5-0.5-5.0-2.2-3.3

-0.3-2.7+2.4-4.7+4.4

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ipca Laboratories has submitted to BSE and NSE the quarterly certificate issued by its Registrar and Share Transfer Agent, MUFG Intime India, under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate confirms that securities received from depository participants for dematerialisation were processed and confirmed to the depositories, and that physical certificates were cancelled after verification and the depositories were substituted as registered owners within prescribed timelines. This is a routine compliance filing.

Likely market impact

Routine regulatory compliance filing. No material impact on operations, financials, or shareholders.